OCALIVA
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
305 Madison Ave, Morristown, New Jersey,...Website
www.ocaliva.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About OCALIVA
It is not known if taking OCALIVA will improve your chance of survival or improve your symptoms of PBC. It is not known if OCALIVA is safe and effective in children. What is the most important information I should know about OCALIVA? OCALIVA may cause serious side effects including: Worsening of liver problems or liver failure, in some cases leading to liver transplant or death, has happened in people with primary biliary cholangitis (PBC) with liver cirrhosis when taking OCALIVA. Before you start OCALIVA, and during your treatment with OCALIVA, your healthcare provider will do tests to check your liver. These tests will help your healthcare provider decide if it is safe for you to start taking OCALIVA and safe for you to continue taking OCALIVA. Tell your healthcare provider right away if you have any of the following symptoms of worsening liver problems during treatment with OCALIVA: Swelling of your stomacharea from a buildup of fluid; yellowing of your skin or the whites of your eyRead more
Popular SearchesOcalivaSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OCALIVA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on OCALIVA recently announced quarterly report
Check if OCALIVA has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once OCALIVA has new funding data
Congratulate Masked Content for being promoted to Masked Content at OCALIVA
OCALIVA, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if OCALIVA had a recent Job posting/layoffs
Product Launch: Get notified when OCALIVA launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OCALIVA is spiking on competitors!
Recommended Actions
Find VP level buyers at OCALIVA
Find 3 more new buyers
Compare Similar Companies to OCALIVA
Compare insights from companies similar to OCALIVA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OCALIVA
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
OCALIVA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OCALIVA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OCALIVA.
OCALIVA Tech Stack
OCALIVA News & Media
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
BOLOGNA, Italy & MORRISTOWN, N.J.--(BUSINESS WIRE)--Alfasigma S.p.A. (“Alfasigma”) and Intercept Pharmaceuticals, Inc. ( “Intercept”) announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc. Following the completion of Alfasigma’s successful tender offer to purchase all outstanding shares of common stock of Intercept for USD 19.00 per share, net to the seller thereof in cash, without interest, less any applicabIntercept reaches agreement with Dr. Reddy’s on generic Ocaliva
Intercept has granted Dr. Reddy’s a non-exclusive, royalty-free license to commercialize its generic version of Ocaliva in the United States.Intercept Announces Updated Ocaliva® (obeticholic acid) U.S. Prescribing Information
New contraindication applies to a subset of patients with primary biliary cholangitis (PBC) with decompensated cirrhosis, a prior decompensation event, or with compensated cirrhosis who have evidence of portal hypertension New contraindication applies to a subset of patients with primary biliary cholangitis (PBC) with decompensated cirrhosis, a prior decompensation event, or with compensated cirrhosis who have evidence of portal hypertension
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding OCALIVA
Sign Up For FreeTo access detailed company insights
It is not known if taking OCALIVA will improve your chance of survival or improve your symptoms of PBC. It is not known if OCALIVA is safe and effective in children. What is the most important information I should know about OCALIVA? OCALIVA may cause serious side effects including: Worsening of liver problems or liver failure, in some cases leadin... Read More
